TY - JOUR
T1 - How to manage secondary pulmonary hypertension. Recognizing and treating cor pulmonale and chronic thromboembolism
AU - Ricciardi, Mark J.
AU - Rubenfire, Melvyn
PY - 1999/2
Y1 - 1999/2
N2 - Establishing an underlying cause and treatment plan for patients with pulmonary hypertension presents a significant challenge to practicing physicians. Doppler echocardiography is a simple, cost-effective tool for detecting pulmonary hypertension and evaluating right ventricular function. Nonspecific therapy (use of digoxin and diuretics, anticoagulation) for pulmonary hypertension and right ventricular failure achieves a degree of symptomatic improvement and should be considered in patients with moderate to severe disease. CTEPH should be considered in patients with dyspnea. Because severe forms of pulmonary hypertension usually are not discovered until late in the disease course, a high level of suspicion is required when evaluating symptoms and risk factors consistent with pulmonary vascular disease. Pulmonary hypertension is classified as idiopathic, or primary, when no secondary cause can be identified. Primary pulmonary hypertension is a devastating disease that largely affects young women. Significant advances in treatment have been made and will be discussed in detail in part 2 of this article.
AB - Establishing an underlying cause and treatment plan for patients with pulmonary hypertension presents a significant challenge to practicing physicians. Doppler echocardiography is a simple, cost-effective tool for detecting pulmonary hypertension and evaluating right ventricular function. Nonspecific therapy (use of digoxin and diuretics, anticoagulation) for pulmonary hypertension and right ventricular failure achieves a degree of symptomatic improvement and should be considered in patients with moderate to severe disease. CTEPH should be considered in patients with dyspnea. Because severe forms of pulmonary hypertension usually are not discovered until late in the disease course, a high level of suspicion is required when evaluating symptoms and risk factors consistent with pulmonary vascular disease. Pulmonary hypertension is classified as idiopathic, or primary, when no secondary cause can be identified. Primary pulmonary hypertension is a devastating disease that largely affects young women. Significant advances in treatment have been made and will be discussed in detail in part 2 of this article.
UR - http://www.scopus.com/inward/record.url?scp=0032986021&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0032986021&partnerID=8YFLogxK
U2 - 10.3810/pgm.1999.02.558
DO - 10.3810/pgm.1999.02.558
M3 - Review article
C2 - 10026712
AN - SCOPUS:0032986021
SN - 0032-5481
VL - 105
SP - 183
EP - 190
JO - Postgraduate medicine
JF - Postgraduate medicine
IS - 2
ER -